Back

Presentation

MERCK Erbitux-Bavencio

MERCK Presentation: Erbitux and Bavencio MERCK’s presentation highlights two of their key oncology…

This website stores cookies on your computer. Cookie & Privacy Policy

MERCK Erbitux-Bavencio

MERCK Presentation: Erbitux and Bavencio MERCK’s presentation highlights two of their key oncology treatments: Erbitux and Bavencio. Erbitux (cetuximab) is a monoclonal antibody that…

  • Date

    10-dec-2023

  • Client

    MERCK

  • Theme

    MERCK Presentation: Erbitux and Bavencio

View Project